Literature DB >> 21729509

Quality of life of patients with congenital heart diseases.

Ana M Silva1, Cláudia Vaz, Maria E G Areias, Daniela Vieira, Cidália Proença, Victor Viana, Cláudia Moura, José C Areias.   

Abstract

OBJECTIVES: To assess the perception of the quality of life of adolescents and young adults with congenital heart disease and to examine the variables that have a negative impact on it and that add a resilience effect.
METHODS: A total of 22 male and 18 female patients, aged 12-26 years, of whom 27 were admitted to surgery and 13 were not, participated in this study. All patients had complete medical records and were interviewed once; demographic and clinical data were collected, and patients filled a questionnaire on quality of life, the WHOQOL-BREF, and underwent an interview on social support, educational style, self-image, functional limitations, and emotional adjustment. RESULTS/
CONCLUSIONS: Our patients showed a better perception of quality of life than did the general population, on the basis of psychological, social relationship and environment scales. Older patients hold a better perception of quality of life on the psychological scale. Cyanosis did not show any significant impact over perception of quality of life decay; however, the number of surgical procedures and the persistence of moderate-to-severe residual injuries had considerable detrimental effect. Social support had an impact on increasing resilience, promoting adjustment to illness. Several factors may play a role in adjustment to congenital heart disease, either improving the perception of quality of life or worsening it. We may conclude that some buffer variables on congenital heart disease may play roles in increasing the perception of quality of life of patients during their lifetime, social support probably explaining why the perception of quality of life is better than in the normal population. The number of surgeries and the moderate-to-severe residual injuries, however, reverted that effect.

Entities:  

Mesh:

Year:  2011        PMID: 21729509     DOI: 10.1017/S1047951111000576

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  6 in total

1.  Self-Reported Health Experiences of Children Living with Congenital Heart Defects: Including Patient-Reported Outcomes in a National Cohort Study.

Authors:  Rachel Louise Knowles; Valerija Tadic; Ailbhe Hogan; Catherine Bull; Jugnoo Sangeeta Rahi; Carol Dezateux
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 2.  Quality of life in adult congenital heart disease: what do we already know and what do we still need to know?

Authors:  Silke Apers; Koen Luyckx; Philip Moons
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

3.  Assessment of Quality of Life in Young Patients with Single Ventricle after the Fontan Operation.

Authors:  Karen Uzark; Victor Zak; Peter Shrader; Brian W McCrindle; Elizabeth Radojewski; James W Varni; Kaitlyn Daniels; Jill Handisides; Kevin D Hill; Linda M Lambert; Renee Margossian; Victoria L Pemberton; Wyman W Lai; Andrew M Atz
Journal:  J Pediatr       Date:  2015-12-10       Impact factor: 4.406

Review 4.  Quality of life and congenital heart disease in childhood and adolescence.

Authors:  Juliana Bertoletti; Giovana Caroline Marx; Sérgio Pedro Hattge Júnior; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2013-12-21       Impact factor: 2.000

5.  Health-related quality of life in children and adolescents undergoing intraoperative device closure of isolated perimembranous ventricular septal defects in southeastern China.

Authors:  Jiang-Shan Huang; Shu-Ting Huang; Kai-Peng Sun; Zhi-Nuan Hong; Liang-Wan Chen; Yur-Ren Kuo; Qiang Chen
Journal:  J Cardiothorac Surg       Date:  2019-12-16       Impact factor: 1.637

6.  Poverty, quality of life and psychological wellbeing in adults with congenital heart disease in Chile.

Authors:  Rodrigo López Barreda; Alonso Guerrero; Juan Cristóbal de la Cuadra; Manuela Scotoni; Wilbaldo Salas; Fernando Baraona; Francisca Arancibia; Polentzi Uriarte
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.